NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

RecruitingN/A

Sponsor: Boston Scientific Corporation

Conditions: Parkinson Disease, Dystonia, Essential Tremor, Movement Disorders

Interventions: Radiofrequency Ablation

Countries: Germany, United Kingdom

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain or for CNS applications per local Directions for Use (DFU)
* Signed a valid, IRB/EC/REB-approved informed consent form

Exclusion Criteria:

* Meets any contraindications per locally applicable Directions for Use (DFU)
* Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

Locations (4)

Cologne, Germany
Düsseldorf, Germany
Würzburg, Germany
London, United Kingdom